Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study

Hideo Nunome,Hiroshi Sakura,Naotake Hashimoto,Kazuo Sasamoto,Hiroshi Ohashi,Sumiko Hasumi,Noriko Ujihara,Tadasu Kasahara,Osamu Tomonaga,Masashi Honda,Yasuhiko Iwamoto

Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study

2018

Hideo Nunome
Hiroshi Sakura
Naotake Hashimoto
Kazuo Sasamoto
Hiroshi Ohashi
Sumiko Hasumi
Noriko Ujihara
Tadasu Kasahara
Osamu Tomonaga
Masashi Honda
Yasuhiko Iwamoto

Objective As a subanalysis of the Januvia Multicenter Prospective Trial in Type 2 Diabetes (JAMP study), we examined factors that decreased blood glucose control effect of sitagliptin after 3 months and patients requiring an addition or increase of diabetes treatment.

Keywords:

Sitagliptin
Type 2 diabetes
Type 2 Diabetes Mellitus
Therapeutic effect
Internal medicine
Medicine
Diabetes mellitus
prospective trial
glucose control
diabetes treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations